JPMorgan Supports Takeda Acquisition of Shire

Takeda Pharmaceutical entered into a 364-day bridge credit agreement for an aggregate principal amount of up to $30.85 billion to finance its acquisition of Shire. JPMorgan served as administrative agent on the transaction.

Barclays Agents $18B Bridge Facility to Support Shire Acquisition

Shire and Baxalta have reached an agreement under which Shire will combine with Baxalta. Shire secured a $18 billion bridge facility commitment from a lender group led by Barclays Bank as agent

Morgan Stanley, Goldman Others Advise Shire on ViroPharma Acquisition

Shire and ViroPharma announced the companies have entered into a merger agreement in which Shire will acquire all the outstanding shares of ViroPharma. Lazard and Morgan Stanley are acting as joint financial advisors to Shire.